CIK 0001595248
- Non-accelerated filer
- Smaller reporting company
Genprex, Inc.
Sign in to watch- Ticker
- GNPX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 900772347
- Phone
- +1 512-537-7997
- Business address
- 3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-18 | Varner John Rodney Chairman, President and CEO | Shares withheld for taxes | −2,642 | $4.40 | $12K | 26,352 |
| 2023-04-21 | Varner John Rodney Chairman, President and CEO | Purchase | +19,000 | $1.06 | $20K | 20,800 |
| 2023-02-18 | Varner John Rodney President & CEO | Grant or award | +625,000 | 1,159,735 | ||
| 2022-02-04 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +1,062,250 | 1,062,250 | ||
| 2021-03-19 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +460,000 | 460,000 | ||
| 2020-08-21 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +530,000 | 530,000 | ||
| 2019-09-05 | Varner John Rodney Chief Executive Officer | Purchase | +1,800 | $0.89 | $2K | 1,800 |
| 2019-01-25 | Varner John Rodney Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +615,384 | 615,384 | ||
| 2018-11-02 | Varner John Rodney Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +551,284 | 551,284 | ||
| 2018-03-29 | Varner John Rodney Chief Executive Officer | Purchase | +10,000 | $5.00 | $50K | 544,735 |
Page 1 of 1 · 10 trades